Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Best Small/Mid-Cap ETFs of Last Week

Published 08/30/2021, 08:00 AM
Updated 07/09/2023, 06:31 AM

The Russell 2000 Index was a winner last week, having gained 5.1%. The performance of the small-cap index Russell 2000 won over the S&P 500 (up 1.52%), the Dow Jones (up 0.96%), the Nasdaq Composite (2.82%).

The FDA granting the first full U.S. approval to Pfizer PFE /BioNTech’s (BNTX) coronavirus vaccine, Comirnaty (BNT162b) has boosted investors’ confidence in economic reopening-friendly sectors. Moreover, the economy has returned to the pre-pandemic level with the GDP rising 6.5% annually in the second quarter, indicating a sustained recovery from the pandemic-induced recession.

Trillions of dollars of government stimulus spending and increased broad-based vaccinations will continue to power consumer spending and result in robust growth. In fact, the United States is projected to see the fastest economic growth in decades this year.

Looking at Q2 as a whole for the small-cap index, total earnings are expected to be up 242.4% from the same period last year on 32.6% higher revenues. The growth in earnings will follow a 40.7% expansion in Q3 of 2021, a 28.5% gain in Q4 of 2021 and a 17.4% uptick in Q1 of 2022, per the Earnings Trends issued on Aug 18, 2021. The projection seems pretty upbeat (read: Time for 5 Small-Cap Sector ETFs on Earnings Strength?).

Against this backdrop, below we highlight a few small-cap ETF winners of the last week.

ETFs in Focus

Direxion Daily Mid Cap Bull 3X Shares MIDU – Up 10.4%

The fund follows the S&P MidCap 400 Index, which measures the performance of the mid-cap segment of the U.S. equity universe. The Index is a capitalization-weighted index composed of 400 domestic common stocks. The expense ratio of the fund is 1.03% (read: Leveraged ETFs That Gained More Than 50% Last Week).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

ETFMG Prime Junior Silver Miners ETF SILJ – Up 10.3%

The underlying Prime Junior Silver Miners & Explorers Index provides a benchmark for investors interested in tracking public, small-cap companies that are active in silver mining exploration and production industry. The fund charges 69 bps in fees.

ETRACS 2x Leveraged U.S. Size Factor TR ETN IWML – Up 10.1%

The underlying Russell 2000 TR USD Index measures the performance of the small capitalization sector of the U.S. equity market. The fund charges 95 bps in fees.

ALPS Medical Breakthroughs ETF SBIO – Up 9.0%

The underlying S-Network Medical Breakthroughs Index captures research & development opportunities in the pharmaceutical industry. It consists of small-cap and mid-cap pharmaceutical and biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials. The fund charges 50 bps in fees.

ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (MTUL) – Up 8.4%

The underlying MSCI USA Momentum GR USD Index captures large and mid-cap stocks of the US market. The fund charges 95 bps in fees.

Sprott Junior Gold Miners ETF (NYSE:GDX) SGDJ – Up 8.4%

The underlying Solactive Junior Gold Miners Custom Factors Index aims to track the performance of small-capitalization gold companies whose stocks are listed on regulated exchanges. The fund charges 50 bps in fees.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Pfizer Inc. (NYSE:PFE): Free Stock Analysis Report

ETFMG Prime Junior Silver Miners ETF (SILJ): ETF Research Reports

ALPS Medical Breakthroughs ETF (SBIO): ETF Research Reports

Direxion Daily Mid Cap Bull 3X Shares (MIDU): ETF Research Reports

Sprott Junior Gold Miners ETF (SGDJ): ETF Research Reports

ETRACS 2x Leveraged US Size Factor TR ETN (IWML): ETF Research Reports

To read this article on Zacks.com click here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.